Smallwood Wealth Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Hold
135
0.01% 270
2026
Q1
$17.2K Hold
135
0.01% 276
2025
Q4
$16.5K Hold
135
0.01% 272
2025
Q3
$13.5K Hold
135
0.01% 295
2025
Q2
$11.2K Hold
135
0.01% 303
2025
Q1
$10.9K Buy
+135
New +$12.1K 0.01% 299

Other funds holding XBI

Smallwood Wealth Investment Management's XBI Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 135 shares worth $21.4K. The position accounts for 0.01% of the portfolio, ranked #270.

Smallwood Wealth Investment Management first reported a position in XBI in Q1 2025 and has held it in 6 quarters since. 485 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Smallwood Wealth Investment Management held 135 shares of State Street SPDR S&P Biotech ETF worth $21.4K as of Q2 2026.
  • Smallwood Wealth Investment Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #270 holding.
  • Smallwood Wealth Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 6 quarters since.
  • 485 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.